What is the latest price of Bimetinib/Bemetinib in 2025?

Binimetinib/Binimetinib belongs to a class of drugs called kinase inhibitors. It works by blocking the action of abnormal proteins that signal cancer cells to reproduce. This helps stop or slow the spread of cancer cells. Bimetinib is often used with canafenib (Encorafenib) to treat certain types of melanoma (a type of skin cancer) that have spread to other parts of the body or cannot be removed with surgery. Bimetinib is used with canafenib to treat certain types of non-small cell lung cancer (a type of lung cancer) that have spread to other parts of the body.

Bimetinib is available as an oral tablet. It is usually taken twice a day, with or without food, about 12 hours apart. Take bimetinib at about the same time each day, exactly as directed. If the patient vomits after taking the dose, do not take another dose and continue with the regular dosing schedule. Depending on whether the patient experiences any side effects, the doctor may reduce or stop treatment temporarily or permanently.

The original drug Bimetinib has not yet been launched in China, so it is not covered by medical insurance, and its price is still unclear. The European version of bimetinib original drug sold overseas has common specifications of 15mg*84 tablets and 15mg*168 tablets. Each box may be sold for about 20,000 yuan (the price may fluctuate due to the exchange rate), which is relatively expensive. It is understood that the first generic drug of bimetinib has been produced and sold overseas. Its drug ingredients are basically the same as those of the original research. The specification produced by Lucius Pharmaceutical Factory in Laos is 15mg*180 tablets, and the price per box may be more than 6,000 yuan (the price may fluctuate due to the exchange rate).

Reference materials:https://medlineplus.gov/druginfo/meds/a618041.html